• Facebook
  • Yahoo
  • Twitter
  • Google
  • Live
  • Facebook
  • Yahoo
  • Twitter
  • Google
  • Live

Bispecific Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030

1 Jul | By Stella Wilson
Bispecific Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030
Roots Analysis
Image source: https://www.rootsanalysis.com/assets/images/rootsanalysis-logo.png
By: Stella Wilson

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market, 2021-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

·        A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.

·        A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.

·        Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.

·        Key takeaways from the bispecific antibody therapeutics pipeline.

·        An analysis of the initiatives of big biopharma players engaged in this domain.

·        An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.

·        A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.

·        A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.

·        A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.

·        A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

Target Disease Indication

·        Autoimmune Disorders

·        Eye Disorders

·        Genetic Disorders

·        Hematological Malignancies

·        Infectious Diseases

·        Inflammatory Disorders

·        Skin Disorders

Mechanism of Action

·        Cytokines Retargeting / Neutralization

·        Dual Ligands Blocking

·        T-cell Retargeting / Activation

·        Others

Target Antigens

·        CD3 x CD19

·        CD30 x CD16A

·        Factor IXa x Factor X

·        IL-1α x IL-1β

·        IL-13 x IL-4

·        IL-17A x Albumin

·        IL-17A x IL-17F

·        Psl x PcrV

·        TNF-α x HAS

·        VEGF-A x ANG2

·        Others

Antibody Format

·        Asymmetric

·        Fragments

·        Symmetric

·        Others

Key Geographical Region

·        North America

·        Europe

·        Asia-Pacific

Get Customized Report: https://www.rootsanalysis.com/reports/286/request-customization.html

Transcripts of interviews held with the following senior level representatives of stakeholder companies:

·        Martin Steiner (Chief Executive Officer, Synimmune)

·        Ludger Große-Hovest (Chief Scientific Officer, Synimmune)

·        Jane Dancer (Chief Business Officer, F-Star)

·        Siobhan Pomeroy (Senior Director, Business Development, Cytom X)

·        Yinjue Wang (Associate Director, Process Development, Innovent Biologics)

Key companies covered in the report

·        Amgen

·        Ablynx

·        AbbVie

·        Affibody

·        Affimed

·        Alphamab

·        AstraZeneca

·        Avillion

·        Chugai Pharmaceuticals

·        Eddingpharm

·        GSK

·        Merck

·        Merus

·        Roche

·        Regeneron Pharmaceuticals

·        Taisho Pharmaceuticals

·        Zymeworks   

Also Read our Latest Publication

Biopharmaceutical Contract Manufacturing Market

Continuous and Semi-Continuous Bioprocessing Market

Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market

mRNA Therapeutics and Vaccines Market, 2020-2030

T-Cell (CAR-T, TCR, and TIL) Therapies Market

Area of application: Dentistry , Dermatology, Gastroenterology, Gynecology and Obstetrics, Human genetics, Infectious disease and antibiotic resistance, Internal medicine and general medicine, Laboratory and environmental medicine, Neurology, Neurosurgery, Oncology, Ophthalmology Diagnostics and Imaging, Otorhinolaryngology, Pathology, Pediatrics and Neonatology, Pharmacology, Pulmonology, Reproductive Medicine, Rheumatology, Surgery, Urology and Nephrology, Medicine, other applications, Cellular biotechnology, Drug delivery, Molecular diagnostics, Pharmaceuticals (development, production, monitoring), Therapeutics, Tissue enginieering, Health, other applications, Biochemistry, Cell Biology, Developmental biology, Ecology, Genetics, Human biology, Microbiology, Molecular biology, Physiology, Biology, other applications, Other Areas of Application
Methods and Techniques: Endoscopy, General microscopy (white light, confocal, bright field, dark field, phase contrast, DIC etc.), Linear and non-linear fluorescence imaging (confocal LSM, multi-photon, STED, PALM, STORM, SIM, FRET, FRAP, FLIM, etc.), Linear and non-linear vibrational microscopy / imaging (IR, confocal Raman, CARS, SRS etc.), Near-field microscopy (SNOM, AFM, STM, etc.), Optical Coherence Tomography (OCT ), Operating microscopy, Photoacoustic imaging (PAI, MSOT), Polarimetry, Probe and sensor development, Terahertz imaging, Thermography, Microscopy/Imaging, other methods and techniques, ATR / FTIR Spectroscopy, Coherent Back Scattering CBS, Diffuse Optics, Dynamic Light Scattering DLS, Ellipsometry, Fluorescence spectroscopy, Photoluminescence, Reflectance, Terahertz spectroscopy, UV / VIS spectroscopy, Vibrational spectroscopy (Raman, Infrared), Spectroscopy, other methods and techniques, fs LASIC, Laser lithotripsy, Laser Surgery, Laser-based thermotherapy, LASIK, LIBS, Photo-coagulation, Photodynamic therapy, Photonic therapeutic approaches, other methods and techniques, CCD and CMOS sensors and cameras, Fiber optical illumination, Functionalized fibres, Implant manufacturing, Laser , Laser-induced microdissection and catapulting of cells, Laser micromanipulation, Microstructure Fibers, Objectives, Optical clearing, Optical tweezers, Tissue separation / laser scalpels, Enabling Technologies, other methods and techniques, Other Methods and Techniques

Share on Biophotonics.World:  
Share on Social Media:


No comments
You need to sign in to comment

Related Articles


Most Viewed